Accendra Health/$ACH
1D1W1MYTD1Y5YMAX
About Accendra Health
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
- Ticker
- $ACH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 6,500
- Headquarters
- Glen Allen, United States
- Website
- www.accendrahealth.com
Accendra Health Metrics
BasicAdvanced
$93M
-
-$3.95
1.61
-
Price and volume
Market cap
$93M
Beta
1.61
52-week high
$5.69
52-week low
$0.93
Average daily volume
1.6M
Financial strength
Current ratio
0.407
Quick ratio
0.192
Long term debt to equity
-323.321
Total debt to equity
-330.29
Interest coverage (TTM)
0.29%
Profitability
EBITDA (TTM)
288.233
Gross margin (TTM)
44.83%
Net profit margin (TTM)
-11.41%
Operating margin (TTM)
1.21%
Effective tax rate (TTM)
4.24%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
0.64%
Return on equity (TTM)
26.59%
Valuation
Price to revenue (TTM)
0.035
Price to book
-0.17
Price to tangible book (TTM)
-0.05
Price to free cash flow (TTM)
-0.254
Free cash flow yield (TTM)
-394.10%
Free cash flow per share (TTM)
-4.769
Growth
Revenue change (TTM)
-3.30%
Earnings per share change (TTM)
-74.74%
3-year revenue growth (CAGR)
-36.08%
10-year revenue growth (CAGR)
-12.36%
3-year earnings per share growth (CAGR)
44.38%
10-year earnings per share growth (CAGR)
8.22%
What the Analysts think about Accendra Health
Analyst ratings (Buy, Hold, Sell) for Accendra Health stock.
Accendra Health Financial Performance
Revenues and expenses
Accendra Health Earnings Performance
Company profitability
Accendra Health News
AllArticlesVideos
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
Business Wire2 weeks ago
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
Business Wire3 weeks ago
Accendra Health Reports Second Quarter 2026 Financial Results
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.